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Adoptive transfer of haploidentical natural killer (NK)
cells can induce remissions in patients with AML.
Despite lymphodepleting chemotherapy failure may
result from suppression by host regulatory T cells (Treg).
We report outcomes of 57 refractory AML patients trea-
ted with cyclophosphamide and fludarabine followed by
haploidentical NK cells and exogenous IL-2 to facilitate
NK proliferation. We augmented Treg lymphodepletion
with IL-2-Diphteria toxin fusion protein (IL2DT) in 15
subjects. NK cell-enriched product characteristics are
described for three production methods. Day 14 blood
donor NK expansion rates were 10% (no IL2DT) versus
30% (with IL2DT) and day 28 leukemia clearance were
25% versus 53% (with IL2DT; p=0.06), suggesting clinical
efficacy of IL2DT strategy. Host Treg depletion at day 7
after IL2DT (mean 1% [range 0-4.7%]) correlated with
donor NK cell expansion (p=0.01). The only factor corre-
lating with AML clearance was donor chimerism detect-
able a week after NK cell infusion (mean 49.5%). In vitro,
Tregs co-incubated with NK cells exhausted added IL-2
(0.25ng/ml) and suppressed NK cells proliferation.
Higher amounts of IL-2 (10ng/ml l) or IL15 (0.5ng/ml )
lead to unaltered NK cell proliferation in vitro even at
high NK:Tregs ratios. Future clinical improvements in
adoptive cell therapy might include alternate methods of
Treg depletion and the use of IL-15 to augment NK cell
expansion.
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